http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-525733-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D451-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
filingDate 2001-09-28^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e64c620a79a743ddbdcc54f1f7c62edb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b01cb261bb32df00c5b3fda329abd43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65b9ecebdf08d1c97f474db7fd97dbb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fee73f0e7ffd5d0f532827f616187088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e4282b4714833c25ccda6bf5d545f1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7f71840da8a2e0057ee3ef90c62f03f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f49ac283c87f1ba4ff02bebccd72bb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18a5ee54411ed93f13886c1bbf71f514
publicationDate 2005-01-28^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NZ-525733-A
titleOfInvention Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
abstract A crystalline monohydrate of (1á, 2â, 4â, 5á, 7â)-7-[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane-bromide (tiotropium bromide monohydrate). A process for the production of the abovementioned compound is also disclosed and pharmaceutical compounds having an anticholinergic activity, suitable for the treatment of COPD and asthma.
priorityDate 2000-10-12^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450956008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11431811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5487427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431778410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID2048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Showing number of triples: 1 to 41 of 41.